Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$903,192
-$183,335 QoQ
Shares Held
37,508
-3.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#1,391
of 2,821 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hartford Funds Management Co LLC holds $9,254,965 across 5 Drug Manufacturers - General names. PFE ranks #5 (9.8% of the industry book) .
All Filings in PFE
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $903,192 | 37,508 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,086,527 | 38,694 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $902,127 | 36,230 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $805,957 | 31,631 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $838,704 | 34,600 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $863,004 | 34,057 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $778,045 | 29,327 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $921,218 | 31,832 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $842,645 | 30,116 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $677,655 | 24,420 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $627,478 | 21,795 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $521,067 | 15,709 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $807,766 | 22,022 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $767,815 | 18,819 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $883,121 | 17,235 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $260,459 | 5,952 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $225,973 | 4,310 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||